Florida monoclonal antibody sites closed after FDA revokes EUA for treatment – NBC 6 South Florida

All Florida monoclonal antibody sites have been closed until further notice after the Food and Drug Administration revoked emergency use approvals for two COVID-19 antibody drugs, the state health department said.

The FDA said Monday that Regeneron and Eli Lilly’s antibody drugs should no longer be used because they are unlikely to work against the Omicron variant, which is now responsible for nearly all U.S. infections.

If the drugs prove effective against future variants, the FDA said it could reauthorize their use.

The U.S. government temporarily halted distribution of the two drugs in late December as omicron raced around the dominant variant nationwide. But officials resumed distribution after complaints from Republican governors, including Gov. Ron DeSantis, who claimed the drugs continued to help some Omicron patients.

DeSantis has heavily promoted antibody drugs as a signature part of his administration’s COVID-19 response, setting up IV sites and praising them at press conferences while speaking out against vaccination mandates and other public health measures.


Leave a Reply

Your email address will not be published.